… Administration approved proteasome inhibitor bortezomib (BTZ) as … We performed differential
gene expression and gene set … effect of BTZ was evaluated in three human ATRT-MYC cell …

… such as MG-132, bortezomib, lactalysin, or epoxomicin. In … a compensatory mechanism upon
proteasome inhibition has been … , now enable a substantially differentiated analysis of these …

… form of human SOD[60]. These cells were more sensitive to proteasome inhibition, which …
clinical use based on inhibition of the UPS is bortezomib, a proteasome inhibitor that blocks the …

… Research status on mechanism of proteasome inhibitor MG132 on ovarian cancer[J]. Chinese
Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2018, 14(06): 629-…

… The 26S proteasome inhibitor bortezomib, has … by bortezomib in a human multiple myeloma
cell line. This result supports our hypothesis that prodigiosin might be an IKKβ inhibitor. For …

… processes and guides the mining of proteasome inhibitors (PI) with broad medical … first
proteasome inhibitor put into clinical use belongs to this catagory [84, 90] Bortezomib 1 …

… 团块法对人胚胎干细胞(human embryonic stem cell,hESC)的八聚体… proteasome inhibitor
(bortezomib) and lysosome inhibitor (… staining to measure their effects on COL4-induced down …

… 其中, 针对蛋白酶体抑制剂的研究进展最快, 目前被FDA批准的蛋白酶体抑制剂有bortezomib,carfilzomb和
ixazomb [11, 12] , 已上市并被用于多发性骨髓瘤和套细胞淋巴瘤的治疗.蛋白酶体…

… AIM: To assess the protective effect of the proteasome inhibitor bortezomib on liver fibrosis
… κB抑制蛋白(inhibitor of κB, IκB)的表达来抑制NF-κB的活性[1,2]. 硼替佐米(bortezomib, Bor)是一…

… to 174 phosphorylated proteins significantly differential expressed. Functional enrichment …
, cell cycle and apoptosis. Interestingly, we found that citreovirdin suppressed cell proliferation …